AI in Healthtech India: Building Clinical AI That Meets DPDP & HIPAA Standards

Why Health Data Requires Extra Protection in AI Systems

Health data is categorized as 'sensitive personal data' under DPDP Act 2023, placing it in the highest protection tier. For AI systems, this creates requirements that go beyond standard PII handling. Every AI model that processes, stores, or generates health-related outputs must do so under explicit patient consent for that specific AI use case, a general app consent is insufficient.

For clinical AI specifically, diagnostic support tools, symptom checkers, prescription validation, clinical note summarization, the stakes extend beyond compliance. An incorrect AI output that influences clinical care creates both regulatory exposure and patient safety risk. This is why clinical AI requires human-in-the-loop validation before any AI output reaches a patient-facing interface.

DPDP Requirements for Clinical AI Applications

Consent specificity: Consent for health data AI processing must be specific to the AI use case, not bundled with general terms. A patient consenting to an EHR app does not automatically consent to their data being processed by an LLM for diagnostic support.

Data minimization: Only the minimum health data necessary for the specific AI inference should be sent to an LLM. If a diagnostic AI needs symptoms and vital signs, sending the patient's full medical history violates purpose limitation.

PHI redaction: Before health data reaches any third-party LLM API (OpenAI, Anthropic, Vertex AI), all direct identifiers must be removed: name, DOB, Aadhaar, address, phone, and any data combination that could re-identify the patient.

Data localization: Health records of Indian patients must be processed in Indian infrastructure or in countries on the DPDP-approved cross-border list. This means using Indian cloud regions (AWS ap-south-1, Azure centralindia, GCP asia-south1) for all health data processing.

The Compliant Clinical AI Stack

Layer 1, PHI/Sensitive Data Gateway: BoundrixAI deployed as the AI gateway, configured with healthtech-specific entity detection: MRN, ICD codes, medication names, clinical findings. All health data is routed through detection and redaction before any outbound LLM call.

Layer 2, Consent Management: Each patient has a linked consent record specifying which AI features they have opted into. Data cannot flow to an AI model for a use case the patient has not explicitly consented to.

Layer 3, Sovereign Compute: LLMs for clinical inference are deployed on-premise or in Indian cloud regions using open-source models (Mistral, Llama variants) to avoid cross-border data transfer entirely for the most sensitive workflows.

Layer 4, Human Validation: All clinical AI outputs are classified as 'decision support' rather than 'clinical decision.' A qualified clinician reviews AI suggestions before they are actioned. The audit log records the clinician review event alongside the AI output.